Clinical Trials Directory

Trials / Completed

CompletedNCT03910205

Tumor Necrosis Factor-alpha and Interleukin-18 Levels in Children With Gingivitis and Type 1 Diabetes Mellitus

Gingival Crevicular Fluid Tumor Necrosis Factor-alpha and Interleukin-18 Levels in Children With Gingivitis and Type 1 Diabetes Mellitus

Status
Completed
Phase
Study type
Observational
Enrollment
88 (actual)
Sponsor
Aydin Adnan Menderes University · Academic / Other
Sex
All
Age
7 Years – 14 Years
Healthy volunteers
Accepted

Summary

This study aimed to evaluate the levels of interleukin 18 and tumor necrosis factor-alpha (TNF-α) in gingival crevicular fluid (GCF) of children with type 1 diabetes mellitus and gingivitis.

Detailed description

Eighty eight children (44 with type 1 diabetes mellitus and 44 healty; age range 7-14 years) will be recruited for the study. The children will be classified into four subgroups based on their periodontal status; 1) Children with gingivitis and diabetes mellitus (MG, n=22); 2) Children with type 1 diabetes mellitus with healthy periodontium (MH, n=22); 3)Healthy children with gingivitis (HG, n=22); 4) Healthy children with healthy periodontium (HH, n=22). Probing pocket depth (PPD), gingival index (GI) and plaque index (PI) will be recorded. Interleukin-18 and TNF-α will be analyzed in GCF and saliva samples by ELISA.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTELISAEnzim linked immunoabsorbant assay

Timeline

Start date
2019-04-08
Primary completion
2019-06-30
Completion
2019-06-30
First posted
2019-04-10
Last updated
2019-11-29

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03910205. Inclusion in this directory is not an endorsement.